Search Tag: Senior Vice President of Global Regulatory Affairs

2022 31 Oct

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that  Dr.  Sylvie Peltier  ("Dr. Peltier") has been appointed as Senior Vice President of Global Regulatory Affairs of the Company  with effect from  October 31 st, 2022. She will be responsible...Read more